<?xml version='1.0' encoding='utf-8'?>
<document id="20489031"><sentence text="Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions."><entity charOffset="20-31" id="DDI-PubMed.20489031.s1.e0" text="dalcetrapib" /><entity charOffset="37-48" id="DDI-PubMed.20489031.s1.e1" text="pravastatin" /><entity charOffset="50-62" id="DDI-PubMed.20489031.s1.e2" text="rosuvastatin" /><entity charOffset="67-78" id="DDI-PubMed.20489031.s1.e3" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.20489031.s1.e0" e2="DDI-PubMed.20489031.s1.e0" /><pair ddi="false" e1="DDI-PubMed.20489031.s1.e0" e2="DDI-PubMed.20489031.s1.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s1.e0" e2="DDI-PubMed.20489031.s1.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s1.e0" e2="DDI-PubMed.20489031.s1.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s1.e1" e2="DDI-PubMed.20489031.s1.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s1.e1" e2="DDI-PubMed.20489031.s1.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s1.e1" e2="DDI-PubMed.20489031.s1.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s1.e2" e2="DDI-PubMed.20489031.s1.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s1.e2" e2="DDI-PubMed.20489031.s1.e3" /></sentence><sentence text="Dalcetrapib targets cholesteryl ester transfer protein and increases high-density lipoprotein cholesterol (HDL-C) levels"><entity charOffset="20-37" id="DDI-PubMed.20489031.s2.e0" text="cholesteryl ester" /><entity charOffset="94-105" id="DDI-PubMed.20489031.s2.e1" text="cholesterol" /><entity charOffset="107-112" id="DDI-PubMed.20489031.s2.e2" text="HDL-C" /><pair ddi="false" e1="DDI-PubMed.20489031.s2.e0" e2="DDI-PubMed.20489031.s2.e0" /><pair ddi="false" e1="DDI-PubMed.20489031.s2.e0" e2="DDI-PubMed.20489031.s2.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s2.e0" e2="DDI-PubMed.20489031.s2.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s2.e1" e2="DDI-PubMed.20489031.s2.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s2.e1" e2="DDI-PubMed.20489031.s2.e2" /></sentence><sentence text=" It is in clinical development for the prevention of cardiovascular events and will likely be used in combination with standard of care, including statins" /><sentence text=" Three crossover studies in healthy males investigated the pharmacokinetic drug-drug interaction potential of 900 mg dalcetrapib and statins: two 3-period studies (dalcetrapib plus pravastatin or rosuvastatin) and a 2-period study (dalcetrapib plus simvastatin)"><entity charOffset="117-128" id="DDI-PubMed.20489031.s4.e0" text="dalcetrapib" /><entity charOffset="181-192" id="DDI-PubMed.20489031.s4.e1" text="pravastatin" /><entity charOffset="196-208" id="DDI-PubMed.20489031.s4.e2" text="rosuvastatin" /><entity charOffset="232-243" id="DDI-PubMed.20489031.s4.e3" text="dalcetrapib" /><entity charOffset="249-260" id="DDI-PubMed.20489031.s4.e4" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e0" e2="DDI-PubMed.20489031.s4.e0" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e0" e2="DDI-PubMed.20489031.s4.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e0" e2="DDI-PubMed.20489031.s4.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e0" e2="DDI-PubMed.20489031.s4.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e0" e2="DDI-PubMed.20489031.s4.e4" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e1" e2="DDI-PubMed.20489031.s4.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e1" e2="DDI-PubMed.20489031.s4.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e1" e2="DDI-PubMed.20489031.s4.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e1" e2="DDI-PubMed.20489031.s4.e4" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e2" e2="DDI-PubMed.20489031.s4.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e2" e2="DDI-PubMed.20489031.s4.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e2" e2="DDI-PubMed.20489031.s4.e4" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e3" e2="DDI-PubMed.20489031.s4.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s4.e3" e2="DDI-PubMed.20489031.s4.e4" /></sentence><sentence text=" Effect on lipids and safety were secondary end points" /><sentence text=" The 900 mg dose investigated is higher than the 600 mg dose currently being investigated in Phase III" /><sentence text=" Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin was not associated with significant increases in statin exposure except for a 26% increase in rosuvastatin C(max) (90% CI 1"><entity charOffset="21-32" id="DDI-PubMed.20489031.s7.e0" text="dalcetrapib" /><entity charOffset="38-49" id="DDI-PubMed.20489031.s7.e1" text="pravastatin" /><entity charOffset="51-63" id="DDI-PubMed.20489031.s7.e2" text="rosuvastatin" /><entity charOffset="68-79" id="DDI-PubMed.20489031.s7.e3" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.20489031.s7.e0" e2="DDI-PubMed.20489031.s7.e0" /><pair ddi="false" e1="DDI-PubMed.20489031.s7.e0" e2="DDI-PubMed.20489031.s7.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s7.e0" e2="DDI-PubMed.20489031.s7.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s7.e0" e2="DDI-PubMed.20489031.s7.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s7.e1" e2="DDI-PubMed.20489031.s7.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s7.e1" e2="DDI-PubMed.20489031.s7.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s7.e1" e2="DDI-PubMed.20489031.s7.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s7.e2" e2="DDI-PubMed.20489031.s7.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s7.e2" e2="DDI-PubMed.20489031.s7.e3" /></sentence><sentence text="088 to 1" /><sentence text="468) but not AUC(0-24) (90% CI 0" /><sentence text="931 to 1" /><sentence text="085)" /><sentence text=" Dalcetrapib AUC(0-24) and C(max) were not significantly altered by coadministration with pravastatin, and were significantly lower when dalcetrapib was coadministered with rosuvastatin or simvastatin compared with dalcetrapib alone"><entity charOffset="90-101" id="DDI-PubMed.20489031.s12.e0" text="pravastatin" /><entity charOffset="137-148" id="DDI-PubMed.20489031.s12.e1" text="dalcetrapib" /><entity charOffset="173-185" id="DDI-PubMed.20489031.s12.e2" text="rosuvastatin" /><entity charOffset="189-200" id="DDI-PubMed.20489031.s12.e3" text="simvastatin" /><entity charOffset="215-226" id="DDI-PubMed.20489031.s12.e4" text="dalcetrapib" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e0" e2="DDI-PubMed.20489031.s12.e0" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e0" e2="DDI-PubMed.20489031.s12.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e0" e2="DDI-PubMed.20489031.s12.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e0" e2="DDI-PubMed.20489031.s12.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e0" e2="DDI-PubMed.20489031.s12.e4" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e1" e2="DDI-PubMed.20489031.s12.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e1" e2="DDI-PubMed.20489031.s12.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e1" e2="DDI-PubMed.20489031.s12.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e1" e2="DDI-PubMed.20489031.s12.e4" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e2" e2="DDI-PubMed.20489031.s12.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e2" e2="DDI-PubMed.20489031.s12.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e2" e2="DDI-PubMed.20489031.s12.e4" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e3" e2="DDI-PubMed.20489031.s12.e3" /><pair ddi="false" e1="DDI-PubMed.20489031.s12.e3" e2="DDI-PubMed.20489031.s12.e4" /></sentence><sentence text=" The HDL-C increase with dalcetrapib was not compromised by coadministration with statins, and reduction in low-density lipoprotein cholesterol with dalcetrapib coadministered with statins was greater than with statins alone"><entity charOffset="25-36" id="DDI-PubMed.20489031.s13.e0" text="dalcetrapib" /><entity charOffset="132-143" id="DDI-PubMed.20489031.s13.e1" text="cholesterol" /><entity charOffset="5-15" id="DDI-PubMed.20489031.s13.e2" text="HDL-C" /><pair ddi="false" e1="DDI-PubMed.20489031.s13.e2" e2="DDI-PubMed.20489031.s13.e2" /><pair ddi="false" e1="DDI-PubMed.20489031.s13.e2" e2="DDI-PubMed.20489031.s13.e0" /><pair ddi="false" e1="DDI-PubMed.20489031.s13.e2" e2="DDI-PubMed.20489031.s13.e1" /><pair ddi="false" e1="DDI-PubMed.20489031.s13.e0" e2="DDI-PubMed.20489031.s13.e0" /><pair ddi="false" e1="DDI-PubMed.20489031.s13.e0" e2="DDI-PubMed.20489031.s13.e1" /></sentence><sentence text=" Dalcetrapib alone and coadministered with statins was generally well tolerated" /><sentence text="" /></document>